Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › High concentration alpha-glucosidase compositions for the treatment of Pompe disease

High concentration alpha-glucosidase compositions for the treatment of Pompe disease

US Patent 10046033 · Granted Aug 14, 2018

Estimated economic value: $28,277,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

High concentration alpha-glucosidase compositions for the treatment of Pompe dis2025
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2025
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2025
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2025
Augmented acid alpha-glucosidase for the treatment of Pompe disease2025
Recombinant human acid alpha-glucosidase2025
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estr2025
Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis 2023
Lipoxin and lipoxin analogue mediated neuroprotection and treatments2022
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2022
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2022
High concentration alpha-glucosidase compositions for the treatment of Pompe dis2022